Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Middle-aged Black adults living with HIV reported substantial economic impact of COVID-19 and high medical mistrust.
Kenya has been using similar technology for three years. DC’s efforts are among the first in the United States.
A new study indicates that the level of adherence required for viral suppression may be lower than previously understood.
The trial will investigate whether injections of long-acting cabotegravir and rilpivirine yield a superior rate of viral suppression.
A $3.5 million grant to the University of Illinois at Chicago will help researchers find out.
Why aren’t the very young people whom Truvada as pre-exposure prophylaxis would help the most using this HIV prevention pill?
A speedy overview of the major scientific findings presented at the International AIDS Conference in Amsterdam (AIDS 2018)
More Black women wise up to PrEP as a way to protect themselves from HIV.
A six-month implant of risperidone might be a good alternative to oral doses. Here’s why.
Forgetting to take your prescribed medication is a bad habit that could kill you, new findings suggest.
Long-acting antiretroviral shots could replace oral treatments for the virus.
State legislators will no longer push for a lifetime ban on hepatitis C treatment for people on Medicaid who do not adhere to treatment.
A counseling-based intervention has succeeded in improving adherence to antiretrovirals among HIV-positive blacks and Latinos who are reluctan...
Researchers say medicine microchips would come pre-loaded with drugs, be implanted in our bodies and then be programmed to give us meds at any...
Are HIV-positive pregnant women taking their meds properly to suppress the virus? An analysis says no.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.